Stay updated on Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial
Sign up to get notified when there's something new on the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page.

Latest updates to the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added and older notices (Revision: v3.4.1 and a government funding status notice) were removed, indicating a UI/version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedA new revision v3.4.1 was added and v3.4.0 removed, and a site-wide notice regarding government funding and NIH operations was introduced. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedUI/formatting updates on the history page include a glossary toggle, color-coded change indicators (green for additions, red for deletions), and updated revision metadata to v3.4.0. The capitalization of the No FEAR Act label was adjusted.SummaryDifference0.5%

- Check42 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4, indicating a minor site update with no changes to study data or history details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page history shows an addition of Revision: v3.3.3 and deletions of HHS Vulnerability Disclosure and Revision: v3.3.2, indicating administrative updates to the site’s footer and history entries. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision label in the site footer updated from v3.2.0 to v3.3.2. No changes to study data, layouts, or navigation were observed.SummaryDifference0.1%

Stay in the know with updates to Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page.